Meilleurs médecins de cancer de l'intestin grêle à l'étranger — Page 5

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Le Dr Pastrana est un chirurgien oncologue certifié spécialisé dans le cancer de l'intestin grêle à l'hôpital Galenia.

• Certifié par Conacem jusqu'en 2030
• Membre de la Société mexicaine d'oncologie (SMEO)
• Enseignant universitaire à l'Universidad Anahuac depuis 2020
• Formé au Centro Medico Nacional 20 de Noviembre

La Prof. Elke Jaeger est l'une des meilleures oncologues d'Allemagne selon le classement Focus, spécialisée dans les sarcomes à la clinique Nordwest.

• Chef du service d'oncologie et d'hématologie à la clinique Nordwest
• 41 années d'expérience en pratique oncologique
• Spécialiste reconnue dans le traitement des sarcomes

Le Dr Tarkan est spécialisé dans les chirurgies complexes du cancer de l'estomac et de l'intestin grêle, avec un accent sur les techniques avancées.

• Membre de l'Association turque de chirurgie bariatrique
• Affilié à la Fédération internationale de chirurgie de l'obésité et des troubles métaboliques
• Diplômé de la faculté de médecine de l'université de Dicle

Le professeur associé Nail Paksoy est spécialisé dans les cancers gastro-intestinaux à l'hôpital Medipol Bahçelievler, avec un accent particulier sur le cancer de l'intestin grêle.

• Oncologue certifié par l'ESMO
• Co-investigateur dans 8 essais cliniques internationaux sur les traitements contre le cancer
• Auteur de multiples articles de recherche sur les cancers gastro-intestinaux et rares
• Formation spécialisée à l'Institut d'oncologie de l'Université d'Istanbul

Plus de 500 interventions réussies de fundoplicature de Nissen et Toupet – Le Dr Braun est spécialisé dans les techniques laparoscopiques mini-invasives pour la chirurgie gastro-intestinale.

• _doctor_7234_années_ d'expérience en chirurgie gastro-intestinale
• Chirurgien général certifié avec une spécialisation
• Formé à l'Université Johns Hopkins en chirurgie hépatobiliaire et pancréatique
• Membre des sociétés professionnelles SICOB et ACOI

Professeur en oncologie radiothérapique avec 31 années d'expérience dans le traitement du cancer – actuellement à l'Université Medipol d'Istanbul.

• Formé à l'Université d'Istanbul et à l'Université Kadir Has
• Maître de conférences puis professeur titulaire à l'Université Demiroglu Bilim
• Travaille dans les services d'oncologie radiothérapique des principaux hôpitaux d'Istanbul
• Traite des cas complexes nécessitant une radiothérapie de précision

Le Dr Ayşe İrem Yasin est oncologue médical à l'hôpital de district Medipol Acıbadem à Istanbul. Elle détient le prestigieux certificat du conseil de l'ESMO. Le Dr Yasin est spécialisée dans les tumeurs solides, notamment les cancers du sein, du poumon et gastro-intestinaux. Elle traite des cas complexes tels que le carcinome à cellules de Merkel et les cancers de primitif inconnu.

• Formée à la Harvard Medical School, à la Cleveland Clinic et à l'hôpital universitaire de Bâle.
• A effectué un stage d'observation clinique dans l'unité de cancer du sein à Novare, en Italie.
• Traite les tumeurs malignes du cerveau et du SNC, les sarcomes des tissus mous et les cancers urologiques.
• Travaille dans un établissement accrédité par la JCI et équipé du système robotique da Vinci.

Le Dr Topcu apporte son expérience internationale en oncologie, acquise au MD Anderson et au Sunnybrook Odette Cancer Center, à l'hôpital universitaire Biruni.

• Spécialisé dans les cancers gastro-intestinaux, y compris les tumeurs de l'intestin grêle
• Membre de l'ESMO et de l'ASCO – suit les normes de traitement mondiales
• Formé dans les meilleurs centres de cancérologie aux États-Unis et au Canada
• Travaille avec des équipes multidisciplinaires pour une prise en charge complète du cancer

Le Dr Atakan Topcu est oncologue médical à l'hôpital Medipol Acibadem District d'Istanbul. Il est spécialisé dans le traitement des tumeurs solides, notamment les cancers du poumon, du sein et colorectal. Le Dr Topcu est professeur associé et auteur de plus de 50 publications scientifiques évaluées par des pairs. Il siège au comité de rédaction de la revue médicale BMC Cancer.

• Expertise en immunothérapie, thérapies ciblées et oncologie gériatrique.
• Traite la dénutrition liée au cancer, la cachexie et la sarcopénie.
• Membre actif de la Société européenne d'oncologie médicale (ESMO).
• Travaille dans un hôpital accrédité par la JCI, spécialisé dans les traitements oncologiques avancés.

Spécialisé en oncologie chirurgicale, y compris les opérations du cancer de l'intestin grêle, avec des techniques laparoscopiques avancées au Dievo Surgery Center.

• Expérience dans le traitement des maladies oncologiques de l'estomac et des intestins
• Réalise des opérations laparoscopiques pour diverses affections abdominales
• Prend en charge les urgences abdominales nécessitant une intervention chirurgicale

Spécialisé en radio-oncologie à l'Université de Marmara – le Dr Sahibov se concentre sur le traitement précis du cancer à l'hôpital Emsey.

• Formé à la faculté de médecine de l'Université de Marmara
• Spécialisé en radio-oncologie pour le cancer de l'intestin grêle
• Diplômé d'un programme médical en anglais

Le professeur Mustafa Ondzhel est spécialisé en chirurgie oncologique, avec un accent sur les cancers du côlon, du rectum et de l'intestin grêle à l'hôpital universitaire Medipol Mega.

• Formé à la Cleveland Clinic en proctologie et chirurgie oncologique
• Certifié par la Commission européenne de coloproctologie
• A publié des recherches sur la résection laparoscopique de l'adénocarcinome rectal
• Chef du département de chirurgie de l'université Medipol d'Istanbul
• Lauréat du prix du « Scientifique le plus performant de l'année » dans le domaine de la santé

La Prof. Dr. Gül Alço est oncologue radiothérapeute avec environ 27 ans d'expérience. Elle traite les cancers du sein, du poumon, de la prostate, gastro-intestinaux, gynécologiques, du système nerveux central, de la tête et du cou, des tissus mous et des os par radiothérapie.

Son expertise comprend la radiothérapie adaptative et la radiochirurgie. Elle utilise des techniques de rayonnement avancées pour fournir des soins personnalisés et fondés sur des preuves dans un cadre multidisciplinaire axé sur le patient.

Le Dr Shruti Kate est spécialisée dans le traitement du cancer de l'intestin grêle et possède une expertise dans l'intervention de Whipple. Elle a été formée au Tata Memorial Hospital, l'un des meilleurs centres de cancérologie en Inde.

• Diplôme en oncologie médicale du Tata Memorial Hospital
• Membre de l'ASCO, de l'ESMO et d'autres sociétés d'oncologie de premier plan
• A présenté des recherches lors de la Conférence mondiale sur le cancer du poumon
• Spécialisée en immunothérapie et en thérapie métronomique

Oncologue radiothérapeute senior spécialisé dans le cancer de l'intestin grêle – Chef du service de radiothérapie au German Oncology Center, Limassol.

• Formé dans des institutions de premier plan, notamment la faculté de médecine de l'université Johann Wolfgang Goethe
• Plus de 13 années d'expérience en oncologie radiothérapique
• Actif dans les techniques de radiothérapie interventionnelle

A réalisé plus de 3 000 chirurgies gastro-intestinales complexes au cours d'une carrière de . Il dirige le département de chirurgie de la clinique Nordwest à Francfort.

• Spécialiste reconnu au niveau national en chirurgie du pancréas et en procédure de Whipple
• Fondateur et directeur de la société allemande « Art of Surgery »
• Dirige un centre interdisciplinaire primé pour les problèmes pancréatiques
• Formé dans des centres de cancérologie de renommée mondiale aux États-Unis, en France et au Japon
• Membre du prestigieux American College of Surgeons (FACS)